Dr Karolin Hijazi
Aberdeen, AB25 2ZR, United Kingdom
Location status: Recruiting
Location contact
Karolin Hijazi, DDS, PhD
CONTACT
Karolin Hijazi, DDS, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT04719026
Heart attack remains a major cause of death in adult population worldwide and especially within Scotland. A large portion of the general population has an increased risk of suffering from a heart attack because of their genetic make-up, disease profile and lifestyle choices.
Literature suggests that apart from these known risk factors, long-standing inflammation (reaction of tissues to infection or injury) elsewhere in the body may be responsible for heart attacks. It has been suggested that gum disease may be one such condition. If left untreated, gum disease may expose the entire body to a long-term inflammatory burden where inflammatory molecules can disseminate from the gums into the bloodstream and affect various body structures. This study explores the influence of gum disease on the risk of heart attack by comparing the gum health of participants who recently had a heart attack to the gum health of participants with no history of heart problems after accounting for other risk factors. Findings will provide critical information for the design of our forthcoming study to establish the effect of treatment of gum disease on the risk of heart attack, and its cost-effectiveness. Ultimately this research will tackle another risk factor for heart attacks and thus inform enhancement of public health prevention strategies.
Interested in participating?
Request Info20 year–90 year
All sexes
Observational
Aberdeen, AB25 2ZR, United Kingdom
Location status: Recruiting
Karolin Hijazi, DDS, PhD
CONTACT
Karolin Hijazi, DDS, PhD
PRINCIPAL_INVESTIGATOR
Coronary artery disease (CAD) is a multifactorial condition leading to most cases of myocardial infarction and results from interaction of genetic, lifestyle and environmental factors. However, as many as 50% of CAD patients lack classical risk factors of CAD suggesting the presence of other contributory mechanisms. Inflammation plays a central role in the initiation and growth of the plaques which form in the arteries (atherosclerosis) and lead to CAD3. As such periodontal disease, an inflammatory process leading to progressive destruction of tooth-supporting structures, has been associated with CAD. In vivo pre-clinical studies have shown that bacteria associated with periodontal disease can exacerbate atherosclerosis 7. Numerous clinical studies have explored the association between periodontal disease and CAD at different follow-up times following episodes of myocardial infarction 8-9. However, there are no reports investigating this association during the acute phase of myocardial infarction. In addition the need for rigorous matching of all known CAD risk factors in case control studies has so far been overseen.
RATIONALE FOR STUDY:
This case-control study aims to compare the health of tooth supporting structures (periodontium) in patients hospitalised for acute myocardial infarction to a control group of patients rigorously matched for known CAD risk factors, age and gender.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
It is an observational study to investigate the prevalence of periodontitis in cases and controls.
Time frame: Single point examination
Our primary objective is the description of periodontal health in patients admitted with acute myocardial infarction compared to matched controls
University of Aberdeen
Other
Acronym: PEDICAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04753749
Arterial Occlusive Diseases, Arteriosclerosis
Sankt Pölten, Austria
View Trial DetailsNCT04968808
Cardiovascular Diseases, Heart Diseases
Gwangju, South Korea
View Trial DetailsNCT06252168
Acute Coronary Syndrome, Cardiovascular Diseases
Tomsk, Russia
View Trial DetailsNCT05198791
Cardiovascular Diseases, Heart Diseases
East Kilbride, Lanarkshire, United Kingdom
View Trial Details